Lemonaid Health vs Oak Longevity: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Oak Longevity beats Lemonaid Health overall, scoring 7.5/10 vs 7.2/10. Lemonaid Health is more affordable at $49/mo vs $130/mo. Choose Lemonaid Health for users who want a low-cost $49/mo membership with flexible me. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.
A side-by-side comparison of Lemonaid Health and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.
Lemonaid Health
#35 of 42Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).
Visit Lemonaid HealthOak Longevity
#23 of 42Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.
Visit Oak Longevity| Feature | Lemonaid Health | Oak Longevity |
|---|---|---|
| Our Score | 7.2/10 | 7.5/10 |
| Starting Price | $49/mo | $130/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a low-cost $49/mo membership with flexible medication options — compounded, microdose, or brand-name Zepbound via LillyDirect | Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin) |
| Ranking | #35 | #23 |
Pros & Cons Compared
Lemonaid Health
Pros
- +2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Established since 2013 with physician-only prescribing and rigorous intake
Cons
- −Membership and medication billed separately — the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
- −Best compounded pricing requires a 6-month commitment
- −The 23andMe acquisition created some uncertainty about the platform's long-term focus
Oak Longevity
Pros
- +$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) and Sesame Care ($99) are lower, but Oak undercuts most mid-tier platforms
- +Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
- +No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
- +Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
- +Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
- +Free shipping and free health coaching included in every program
Cons
- −Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
- −No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
- −'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
- −'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
- −Newer brand without disclosed company history, founding date, or executive team on landing pages
- −Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform
Our Verdict
Oak Longevity edges out Lemonaid Health with a score of 7.5/10 vs 7.2/10. If budget is your priority, Lemonaid Health starts at $49/mo compared to Oak Longevity's $130/mo. Choose Lemonaid Health if you want: users who want a low-cost $49/mo membership with flexible medication options — compounded, microdose, or brand-name zepbound via lillydirect. Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).